EssilorLuxottica (OTCMKTS:ESLOY) Shares Climb 5.6% – Here’s What Happened

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) shares traded up 5.6% on Wednesday. The stock traded as high as $97.03 and last traded at $97.03. 14,054 shares traded hands during mid-day trading, a decline of 90% from the average daily volume of 138,710 shares. The stock had previously closed at $91.90.

Analyst Ratings Changes

A number of research analysts have recently commented on ESLOY shares. Deutsche Bank Aktiengesellschaft upgraded EssilorLuxottica from a “hold” rating to a “buy” rating in a report on Thursday. Kepler Capital Markets cut shares of EssilorLuxottica from a “strong-buy” rating to a “strong sell” rating in a research note on Thursday, September 17th. The Goldman Sachs Group cut shares of EssilorLuxottica from a “buy” rating to a “hold” rating in a research report on Tuesday, July 14th. Royal Bank Of Canada reissued an “outperform” rating on shares of EssilorLuxottica in a report on Tuesday, September 22nd. Finally, Citigroup reiterated a “buy” rating on shares of EssilorLuxottica in a research report on Monday. Two investment analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy”.

EssilorLuxottica Stock Up 1.8%

The business has a fifty day moving average price of $86.98 and a 200 day moving average price of $96.86.

About EssilorLuxottica

EssilorLuxottica is a global company specializing in the design, manufacture and distribution of ophthalmic lenses, eyewear and related optical products. Its activities span the value chain, including lens technology, prescription frames, sunglasses, retail, wholesale distribution and vision-care services.

The company’s portfolio includes well-known eyewear brands such as Ray-Ban, Oakley, Persol, Oliver Peoples, Vogue Eyewear and Costa. Its lens and vision-care brands include Varilux, Crizal, Transitions and Eyezen.